Associate Director, Regulatory Affairs CMC jobs in United States
cer-icon
Apply on Employer Site
company-logo

Acadia Pharmaceuticals Inc. · 1 day ago

Associate Director, Regulatory Affairs CMC

Acadia Pharmaceuticals is committed to making a difference for underserved neurological and rare disease communities. The Associate Director, Regulatory CMC, will contribute to the development and implementation of global regulatory CMC strategies, coordinate regulatory activities for clinical trials, and interact with global regulatory agencies.

BiotechnologyHealth CarePharmaceutical
Hiring Manager
Ben Grieser
linkedin

Responsibilities

Supports CMC regulatory affairs activities for marketed products and compounds in development in line with US and ex-US regulatory requirements
Coordinates with R&D, Pharmaceutical Development, Manufacturing, Quality and Regulatory colleagues and other functional areas to develop and implement CMC regulatory strategy
Organizes and contributes to the timely preparation of high quality CMC sections of INDs/CTAs, NDAs, MAAs and amendments for submission to global regulatory authorities, supporting the conduct of clinical trials and marketing applications
Contributes as a key regulatory representative with external parties for CMC development activities
Interacts with regulatory agencies for CMC development activities as required
Supports the regulatory function on development teams providing CMC regulatory guidance and strategy including identifying and assessing/mitigating regulatory risks
Participates in ensuring compliance of CMC activities with applicable regulatory requirements
Evaluates Manufacturing processes and changes, assesses the regulatory implications and supports their implementation
Maintains current knowledge of the relevant guidelines and regulations and determine applicability to company activities
Other duties as assigned

Qualification

CMC Regulatory AffairsIND/CTANDA submissionsGlobal regulatory requirementsCross-functional teamworkAttention to detailMeet deadlinesInterpersonal skillsOrganizational skillsFlexibilityNegotiation skillsEffective communication

Required

Bachelor's degree in a life science or related field
At least 8 years of progressively responsible experience in CMC Regulatory Affairs with a focus on small molecule drug development
Knowledge and understanding of global regulatory CMC requirements and guidelines
Previous experience in the preparation and submission of the CMC components of IND/CTA and NDA and ex-US MAA submissions
Ability to work in a cross-functional team environment and manage competing priorities
Strong interpersonal skill, attention to detail and excellent organizational, computer, and documentation
Ability to meet deadlines and perform multiple tasks in a fast paced setting
Demonstrated personal initiative, responsibility, flexibility, the ability to work under limited supervision, and ability to handle multiple project assignments
Skilled at negotiating with/influencing business partners and departmental leaders regarding matters of significance to the department or segments of the organization
Adept at communicating a clear vision among team members effectively aligning resources to achieve functional area goals

Benefits

Competitive base, bonus, new hire and ongoing equity packages
Medical, dental, and vision insurance
Employer-paid life, disability, business travel and EAP coverage
401(k) Plan with a fully vested company match 1:1 up to 5%
Employee Stock Purchase Plan with a 2-year purchase price lock-in
15+ vacation days
13 -15 paid holidays, including office closure between December 24th and January 1st
10 days of paid sick time
Paid parental leave benefit
Tuition assistance

Company

Acadia Pharmaceuticals Inc.

twittertwittertwitter
company-logo
Acadia Pharmaceuticals develops and commercializes small molecule drugs for the treatment of central nervous system disorders.

Funding

Current Stage
Public Company
Total Funding
$811.73M
Key Investors
National Institute of Neurological Disorders and StrokeOxford Bioscience PartnersNational Institute of Mental Health
2019-09-17Post Ipo Equity· $287.5M
2018-11-30Post Ipo Equity· $316.25M
2013-01-02Post Ipo Equity· $86.39M

Leadership Team

leader-logo
Catherine Adams
Chief Executive Officer
linkedin
leader-logo
Steve Davis
President and CEO
linkedin
Company data provided by crunchbase